INCOME STATEMENT (Quarterly GAAP In millions $) |
(Nov 30 2021) III. Quarter |
(Aug 31 2021) II. Quarter |
(May 31 2021) I. Quarter |
(Feb 28 2021) IV. Quarter |
(Nov 30 2020) III. Quarter |
Unrealized Gain Loss On Derivatives |
- |
0.19 |
0.18 |
|
5.35 |
Revenue From Contract With Customer Including Assessed Tax |
0.37 |
0.14 |
0.56 |
|
0.12 |
Revenue From Contract With Customer Including Assessed Tax |
- |
- |
- |
|
- |
Increase Decrease In Accounts Payable |
- |
- |
- |
|
- |
Loss On Debt Covenant Violation |
- |
- |
- |
|
- |
Derivative Gain Loss On Derivative Net |
- |
- |
- |
|
- |
Other Revenue |
0.00 |
-0.19 |
-0.18 |
|
-5.35 |
Total Revenue |
0.37 |
0.14 |
0.56 |
0.10 |
0.12 |
Cost of Revenue |
0.14 |
0.04 |
0.11 |
0.03 |
0.02 |
Gross
Profit |
0.23 |
0.10 |
0.45 |
0.07 |
0.10 |
Selling, Administration, Marketing |
3.96 |
2.59 |
1.90 |
0.95 |
0.94 |
Gain (Loss) on Disposition of Assets and Other Investments |
- |
-0.03 |
- |
- |
- |
Depriciation & Amortization |
0.07 |
0.05 |
0.04 |
0.03 |
0.03 |
Research and Development Expense |
0.98 |
0.70 |
0.63 |
0.36 |
0.02 |
Restructuring, Accretion & impairment charges |
-0.16 |
0.07 |
-32.98 |
-0.32 |
0.03 |
Other operatinig exp. /-income |
0.16 |
-0.07 |
32.98 |
0.25 |
-0.03 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Research And Development Expenses |
- |
- |
- |
-0.11 |
- |
Operating Lease Cost |
0.10 |
0.08 |
0.03 |
- |
- |
Total operating costs including COS |
5.26 |
3.43 |
2.71 |
1.19 |
1.02 |
Operating income/-loss
|
-4.89 |
-3.28 |
-2.15 |
-1.09 |
-0.90 |
Other Deductions / - Income |
Interest expense |
2.05 |
1.81 |
0.95 |
0.59 |
1.08 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
2.05 |
1.81 |
0.95 |
0.59 |
1.08 |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
0.16 |
-0.27 |
32.80 |
0.58 |
-5.38 |
Total costs & expenses |
7.47 |
4.97 |
36.47 |
2.37 |
-3.29 |
Income /-loss before income taxes |
-7.09 |
-4.83 |
-35.90 |
-2.26 |
3.41 |
Income taxes expenses/-benefit |
- |
- |
- |
- |
- |
Income after income taxes |
-7.09 |
-4.83 |
-35.90 |
-2.26 |
3.41 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-7.09 |
-4.83 |
-35.90 |
-2.26 |
3.41 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-7.09 |
-4.83 |
-35.90 |
-2.26 |
3.41 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-7.09 |
-4.83 |
-35.90 |
-2.26 |
3.41 |
EBIT |
-5.04 |
-3.02 |
-34.96 |
-1.67 |
4.48 |
EBITD |
-4.98 |
-2.97 |
-34.92 |
-1.64 |
4.51 |
EBITDA |
-3.67 |
-1.89 |
-34.60 |
-1.64 |
4.56 |